Market research
LSH.AU Lifespot Health Ltd
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- -0.5
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- AU0000179475
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- -0.5
About
About Lifespot Health Ltd
Lifespot Health Ltd provides diagnostic systems and delivery platforms to healthcare enterprises in Australia. The company is developing the BodyTel System that integrates multiple sensors for capturing diagnostic information for additional diseases; Seng-Vital, a Bluetooth enabled vaporizer and health platform designed for the use of medical cannabis; and FeverTel, a dual mode digital thermometer to record and track family's symptoms. Lifespot Health Ltd was incorporated in 2016 and is based in Melbourne, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the LSH.AU discussion.
5 years, 5 months ago
Lifespot Health Ltd is currently in a long term uptrend where the price is trading 3.3% above its 200 day moving average.
From a valuation standpoint, the stock is 60.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 101.7.
Lifespot Health Ltd's total revenue rose by 144.3% to $104K since the same quarter in the previous year.
Its net income has increased by 59.5% to $-545K since the same quarter in the previous year.
Finally, its free cash flow grew by 46.1% to $-254K since the same quarter in the previous year.
Based on the above factors, Lifespot Health Ltd gets an overall score of 5/5.